While it is well established that COVID-19 can broadly suppress xenobiotic metabolism pathways, the impact of SARS-CoV-2 infection on CES1 and CES2 activity remains underexplored, and experimental validation in hepatocytes or in vivo models needs to be performed. This evidence concerns the gene CES1 and COVID-19.